ArticleFrontiers in immunology2022

Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors - A phase I trial.

Cathrine Lund Lorentzen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.